FINHUB Insights

STE · Q1 FY26 · Apr 1 – Jun 30, 2025

Steris Q1 FY26: where the revenue came from and where it went

Steris Q1 FY26: revenue $1.4B (+9% year over year). Net profit $0.18B. Largest cohort Healthcare $1.0B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 7, 2025 10-Q
Sankey diagram of Steris's income statement for Q1 FY26: revenue of $1.39 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.39B +9% year over year
Gross profit$0.63B 45% margin
Operating profit$0.25B 18% margin
Net profit$0.18B 13% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.39 100% +9%
Healthcare 0.98 70% +8%
Applied sterilization 0.28 20% +13%
Life science member 0.14 10% +5%
Cost of revenue−0.7655%
Gross profit0.6345% margin+0pp
R&D−0.032%+0pp
SG&A−0.3626%−1pp
Operating profit0.2518% margin+3pp
Tax−0.05
Interest & other costs−0.02
Net profit0.1813%+1pp
Filing on EDGAR More quarters of STE

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.